E�cacy and safety evaluation of a single thermal pulsation system treatment (lipi�ow®) on meibomian gland dysfunction: a randomized controlled clinical trial

HIGHLIGHTS

• who: Meibomian Gland Dysfunction A and colleagues from the Chengdu University of Traditional Chinese Medicine Eye Hospital have published the article: Eufffdcacy and Safety Evaluation of a Single Thermal Pulsation System Treatment (Lipiufffdowu00ae) on Meibomian Gland Dysfunction: A Randomized Controlled Clinical Trial, in the Journal: (JOURNAL)
• what: A single 12-min LipiFlow treatment can ameliorate subjective symptoms of MGD and markedly improve meibomian glands secretion function lasting for at least 3 months.
• how: This study was conducted in compliance with the tenets of the Helsinki Declaration. Repeated measures analysis of variance (ANOVA) was . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.